LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

bioMérieux joins EuropaBio: Advancing QC testing for innovative therapies

22/06/2023

NEWS RELEASE

Brussels, 22 June 2023 - EuropaBio is pleased to announce that bioMérieux has joined the association as Corporate Member.

bioMérieux is a family-owned biotechnology company founded in France. Since 1963, it has been at the forefront of ground-breaking advancements in the field of in vitro diagnostics, making significant contributions to improving public health worldwide. bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

As a world leader in the field of industrial microbiological control, bioMérieux provides diagnostic solutions that detect pathogens and identify microorganisms responsible for contamination at all steps of the manufacturing process as well as within the manufacturing environment in food, pharmaceutical and cosmetic products.

With a partner-first approach to Pharmaceutical Quality Control, the bioMérieux’s experts deliver an integrated offer that easily adapts to facilities, products, and processes, allowing key industry players to provide critical therapies quickly and safely to patients.

EuropaBio Director-General Dr. Claire Skentelbery said “bioMérieux is a valued new member of the EuropaBio community. It reflects Europe’s critical strength and depth behind delivering innovative healthcare. We look forward to their expertise within our work across members within the Healthcare Council and Biomanufacturing Platform.”

bioMérieux (Pharma Quality Control business) Senior VP EMEA Nelly Dumont added “We are very pleased to become a corporate member of EuropaBio's Healthcare Council and Biomanufacturing Platform. Our primary focus is reinforcing the crucial role of quality control in the development and manufacturing of innovative medicine, prioritizing patient safety. Additionally, we aim to establish a robust network with European stakeholders, actively collaborating to strengthen the biotechnology industry in Europe.”

bioMérieux joins EuropaBio: Advancing QC testing for innovative therapies


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

18/09/2023

Genopole joins EuropaBio: French biotechnology on a global scale


Read more
13/09/2023

EU Industrial Forum report: Advanced Manufacturing at the heart of a resilient, sustainable and competitive Europe


Read more
04/09/2023

Factsheet – The Biotech Journey: From Bench to Patients


Read more

Important links

  • Genopole joins EuropaBio: French biotechnology on a global scale
  • Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
LOGO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies